Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (171-180 of 389) with videos related to

Pageof 39
Sort By:
European Journal of Pharmacology|August 20, 2005
Characterisation of imidazoline I2 binding sites in pig brainNeil J Anderson, Patrick A Lupo, David J Nutt, et al.
Biological Psychiatry|August 29, 2006
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitorsGeorge I Papakostas, David J Nutt, Lindsay A Hallett, et al.
European Addiction Research|April 3, 2015
Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patientsHenri-Jean Aubin, Jens Reimer, David J Nutt, et al.
Neuropharmacology|October 17, 2022
Mescaline: The forgotten psychedelicIoanna A Vamvakopoulou, Kelly A D Narine, Ian Campbell, et al.
Neuropharmacology|October 19, 2006
In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sitesLouise M Paterson, Robin J Tyacke, Emma S J Robinson, et al.
Psychopharmacology|July 9, 2009
Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controlsRobin L Carhart-Harris, David J Nutt, Marcus R Munafo, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2019
Antidepressants, withdrawal, and addiction; where are we now?Sameer Jauhar, Joseph Hayes, Guy M Goodwin, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2012
Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trialHelen Bould, Nicola Wiles, John Potokar, et al.
Journal of Psychopharmacology (Oxford, England)|March 23, 2024
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionDavid Erritzoe, Tommaso Barba, Meg J Spriggs, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2011
The effects of 7.5% carbon dioxide inhalation on task performance in healthy volunteersAlison Diaper, David J Nutt, Marcus R Munafò, et al.
Pageof 39

Showing results (171-180 of 389) with videos related to

Sort By:
Pageof 39
European Journal of Pharmacology|August 20, 2005
Characterisation of imidazoline I2 binding sites in pig brainNeil J Anderson, Patrick A Lupo, David J Nutt, et al.
Biological Psychiatry|August 29, 2006
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitorsGeorge I Papakostas, David J Nutt, Lindsay A Hallett, et al.
European Addiction Research|April 3, 2015
Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patientsHenri-Jean Aubin, Jens Reimer, David J Nutt, et al.
Neuropharmacology|October 17, 2022
Mescaline: The forgotten psychedelicIoanna A Vamvakopoulou, Kelly A D Narine, Ian Campbell, et al.
Neuropharmacology|October 19, 2006
In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sitesLouise M Paterson, Robin J Tyacke, Emma S J Robinson, et al.
Psychopharmacology|July 9, 2009
Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controlsRobin L Carhart-Harris, David J Nutt, Marcus R Munafo, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2019
Antidepressants, withdrawal, and addiction; where are we now?Sameer Jauhar, Joseph Hayes, Guy M Goodwin, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2012
Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trialHelen Bould, Nicola Wiles, John Potokar, et al.
Journal of Psychopharmacology (Oxford, England)|March 23, 2024
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionDavid Erritzoe, Tommaso Barba, Meg J Spriggs, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2011
The effects of 7.5% carbon dioxide inhalation on task performance in healthy volunteersAlison Diaper, David J Nutt, Marcus R Munafò, et al.
Pageof 39